Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Medical Research|December 22, 2006
Participation of Runx2 in mandibular condylar cartilage developmentTakako Shimizu
Clinical Pharmacology in Drug Development|April 8, 2020
Randomized, Double-Blind, Single-Dose, Placebo-Controlled Crossover Study to Evaluate the Effects of Esaxerenone on QTc Interval in Healthy SubjectsJeanne Mendell, Fumiaki Kobayashi, Takako Shimizu
Bioscience Trends|May 13, 2014
Substrate specificity of human granzyme 3: analyses of the P3-P2-P1 triplet using fluorescence resonance energy transfer substrate librariesYukiyo Hirata, Hirofumi Inagaki, Takako Shimizu, et al.
Journal of Affective Disorders|August 15, 2006
Actigraphic predictors of the depressive state in students with no psychiatric disordersTomoyuki Kawada, Masao Katsumata, Hiroko Suzuki, et al.
International Journal of Medical Sciences|November 21, 2007
Immunohistochemical characteristics of bone forming cells in pleomorphic adenomaKeisuke Nakano, Takehiro Watanabe, Takako Shimizu, et al.
International Journal of Behavioral Medicine|July 12, 2011
Agreement in regard to total sleep time during a nap obtained via a sleep polygraph and accelerometer: a comparison of different sensitivity thresholds of the accelerometerTomoyuki Kawada, Hiroko Suzuki, Takako Shimizu, et al.
Antiviral Research|March 31, 2007
Suppression of virus replication via down-modulation of mitochondrial short chain enoyl-CoA hydratase in human glioblastoma cellsMegumi Takahashi, Eiji Watari, Eiji Shinya, et al.
Clinical Pharmacology in Drug Development|December 30, 2016
Population Pharmacokinetics of Edoxaban in Japanese Atrial Fibrillation Patients With Severe Renal ImpairmentTakako Shimizu, Masaya Tachibana, Tetsuya Kimura, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 14, 2018
Pharmacokinetics, Metabolism, and Excretion of [14C]Esaxerenone, a Novel Mineralocorticoid Receptor Blocker in HumansMakiko Yamada, Jeanne Mendell, Hideo Takakusa, et al.
Drug Metabolism and Pharmacokinetics|January 21, 2024
Exposure-response analysis of the efficacy and safety of esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with or without diabetic kidney diseaseKazutaka Yoshihara, Masato Fukae, Helen Kastrissios, et al.
Pageof 8